Chester, VA, United States of America

Angela Taylor

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: Wyeth. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Angela Taylor. Retrieved from https://idiyas.com/inventor/angela-taylor-1mwvifiz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Angela Taylor: Innovator in Pharmaceutical Composition

Introduction

Angela Taylor is a notable inventor based in Chester, VA (US). She has made significant contributions to the field of pharmaceuticals, particularly with her innovative approach to chewable tablet formulations.

Latest Patents

Angela holds a patent for a chewable tablet containing phenylephrine. This chewable pharmaceutical composition comprises phenylephrine, an artificial sweetener, and a substantially aldehyde-free matrix. The formulation ensures phenylephrine stability suitable for a typical commercial product with a two-year shelf life. Additionally, the patent includes a method of manufacture for the composition and a method of use.

Career Highlights

Angela Taylor is associated with Wyeth, a prominent company in the pharmaceutical industry. Her work has focused on developing formulations that enhance the stability and usability of pharmaceutical products.

Collaborations

Angela has collaborated with notable coworkers, including Josephine Fubara and Mark Mabry, contributing to the advancement of pharmaceutical innovations.

Conclusion

Angela Taylor's contributions to the pharmaceutical industry, particularly through her patent for a chewable tablet containing phenylephrine, highlight her role as an innovator in the field. Her work continues to impact the development of effective pharmaceutical compositions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…